Loading...
Loading...
CVRX| Name | Value |
|---|---|
| Revenues | 13.4M |
| Cost of Revenue | 2.0M |
| Gross Profit | 11.4M |
| Operating Expense | 24.4M |
| Operating I/L | -13.0M |
| Other Income/Expense | -0.0M |
| Interest Income | -1.0M |
| Pretax | -13.1M |
| Income Tax Expense | -0.2M |
| Net Income/Loss | -13.1M |
CVRx, Inc. is a medical device company specializing in neuromodulation solutions for patients with cardiovascular diseases. Its flagship product, Barostim, is a neuromodulation device designed to alleviate symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company generates revenue by selling its products through a combination of direct sales force, sales agents, and independent distributors in the United States, Germany, rest of Europe, and internationally.
